Both CerAMfacturing and NU-SPINE focused on ceramic components for medical implants, with NU-SPINE explicitly targeting spine surgery materials including silicon nitride, alumina, and osseointegration.
CERAMTEC GMBH
Industrial ceramics manufacturer specializing in medical-grade silicon nitride and alumina implants, additive manufacturing, and ceramic tribology for spine and orthopaedic applications.
Their core work
CeramTec GmbH is an industrial manufacturer of advanced technical ceramics, with particular depth in medical-grade ceramic materials including silicon nitride and alumina. Their core competence lies in translating ceramic materials science into functional components — implants, coatings, and multi-material assemblies — that must meet demanding mechanical, tribological, and biological performance requirements. In EU research projects, they function as the industrial manufacturing partner, contributing production know-how, materials characterization, and applied testing of properties like wear resistance, corrosion behavior, and osseointegration. They bridge academic ceramic research and real-world medical device manufacturing.
What they specialise in
CerAMfacturing (2015–2018) was dedicated to developing ceramic and multi-material components via additive manufacturing methods for personalized medical applications.
NU-SPINE keyword set includes tribology, wear, corrosion, and mechanical properties — indicating CeramTec contributed materials performance testing for implant-grade ceramics.
NU-SPINE (2019–2023) specifically targeted disc replacement (TDR), fusion, and spine implant development, with CeramTec's ceramic expertise directly applicable.
NU-SPINE keywords include coating and osseointegration, suggesting CeramTec contributes surface treatment knowledge critical to implant-bone integration.
How they've shifted over time
In their first H2020 project (2015–2018), CeramTec's focus was firmly on manufacturing process innovation — specifically how additive manufacturing can produce personalized, multi-material ceramic components at industrial scale. By 2019, the emphasis shifted decisively toward clinical application depth: spine surgery, disc replacement, fusion procedures, and the full battery of material performance testing (tribology, corrosion, wear, osseointegration) needed to qualify ceramics for in-body use. This trajectory suggests a move from "how do we make ceramic parts differently" toward "how do we prove ceramic implants work better" — a natural progression for a manufacturer entering regulated medical device markets.
CeramTec is deepening its position in orthopaedic and spinal implant markets, which suggests their strongest future collaboration value lies in projects targeting ceramic biomaterials, implant regulatory validation, or next-generation joint and spine replacement devices.
How they like to work
CeramTec participates exclusively as a consortium partner — they have not coordinated any H2020 project — indicating they prefer to contribute industrial expertise without carrying full administrative and managerial responsibility. Their two projects collectively span 17 unique partners across 9 countries, meaning they are comfortable in mid-to-large multinational consortia. This profile is consistent with a manufacturer that adds high-value technical credibility to academic-led research teams rather than driving project direction.
CeramTec has built connections with 17 distinct consortium partners across 9 countries through just two projects, suggesting each consortium was a genuine multi-partner European collaboration rather than a tight bilateral arrangement. Their network is European in scope, likely spanning German industry alongside academic and research partners from other EU member states.
What sets them apart
CeramTec is one of very few industrial SMEs in Europe that combines ceramic materials manufacturing with validated medical device experience — a combination that is difficult for academic partners to replicate and hard to find in a single organization. Their participation in both a manufacturing innovation project and a prestigious MSCA training network signals recognition by the broader scientific community as a credible industrial mentor and technology provider, not just a supplier. For a consortium building a medical device, materials, or orthopaedics project, CeramTec offers the rare combination of production scale, materials expertise, and clinical-application focus under one roof.
Highlights from their portfolio
- CerAMfacturingThe largest of CeramTec's EU projects by far (EUR 1,076,250), this RIA tackled the ambitious challenge of applying additive manufacturing to personalized ceramic medical components — a topic at the intersection of two demanding fields.
- NU-SPINEAn MSCA Innovative Training Network, this project selected CeramTec as an industrial partner to train the next generation of spine implant researchers — a mark of recognition as a leading practitioner in medical ceramics.